14
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Targeting Naproxen to Non-Parenchymal Liver Cells Protects Against Endotoxin Induced Liver Damage

, , , , &
Pages 303-310 | Received 29 Mar 1996, Accepted 28 Aug 1996, Published online: 20 Oct 2008

References

  • M. Abecassis, J. Falk, L. Makowka, R. Falk, and G. Levy.(1987). 16, 16 dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection J. Clin. Invest 80:881–889.
  • A. Badger, D. Olivera, J. Talmadge, and N. Hanna.(1989). Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism in murine models of endotoxin shock: Inhibition of tumor necrosis factor as a possible mechanism of action Circ. Shock 27:51–61.
  • D. Brater, S. Anderson, and D. BrownCartwright.(1987). Reversible acute decrease in renal function by NSAIDs in cirrhosis Am. J. Med. Sci 294:168–174.
  • J. Devière, J. Content, C. Denys, P. Van den Bussche, L. Schandene, J. Wybran, and E. Dupont.(1990). Excessive in vitro bacterial lipopolysaccharide‐induced production of monokines in cirrhosis Hepatology 11:628–634.
  • J. Ferluga, and A. Allison.(1978). Role of mononuclear infiltrating cells in pathogenesis of hepatitis Lancet ii:610–611.
  • E. Franssen, R. Jansen, M. Vaalburg, and D. Meijer.(1993). Hepatic and intrahepatic targeting of an anti‐inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules Biochem. Pharmacol 45:1215–1226.
  • E. Franssen, F. Molenaar, D. de Zeeuw, and D. Meijer.(1994). Drug targeting to the kidney with low molecular weight proteins Advanced Drug Delivery Reviews 14:67–88.
  • F. Guarner, M. Fremont Smith, and J. Prieto.(1985). Cytoprotective effect of prostaglandins on isolated rat liver cells Liver 5:35–39.
  • D. Häussinger, T. Stehle, and W. Gerok.(1988). Effects of leukotrienes and the thromboxane A2 analogue U‐46619 in isolated perfused rat liver Hoppe‐Sevler's Z. Physiol. Chem 369:97–107.
  • N. Kawada, Y. Mizoguchi, Y. Sakagami, K. Kobayashi, S. Yamamoto, and S. Morosawa.(1990). Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic necrosis model Prostaglandins Leukotrienes Ess. Fatty Acids 40:149–155.
  • N. Kawada, N. Ueda, Y. Mizoguchi, K. Kobayashi, T. Monna, S. Morisawa, K. Ishimura, T. Suzuki, and S. Yamamoto.(1992). Increased 5‐lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration Hepatology 16:462–468.
  • H. Krell, and E. Dietze.(1989). Hemodynamic and metabolic responses to leukotriene C4 in isolated perfused rat liver Hepatology 10:300–305.
  • O. Lowry, N. Rosenbrough, A. Farr, and R. Randall.(1951). Protein measurement with the Folin phenol reagent J. Biol. Chem 193:265–275.
  • D. Meijer, and G. Molema.(1995). Targeting of drugs to the liver Seminars in Liver Disease 15:202–256.
  • Y. Mizoguchi, H. Tsutsui, K. Miyajima, Y. Sakagami, S. Seki, K. Kobayashi, S. Yamamoto, and S. Morisawa.(1987). The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model Hepatology 7:1184–1188.
  • Y. Mizoguchi, Y. Sakagami, S. Seki, K. Kobayashi, S. Yamamoto, and S. Morisama.(1988). Protective effect of leukotriene inhibitor in an experimental massive hepatic cell necrosis Gastroent. Jap 23:263–267.
  • W. Powell.(1980). Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica Prostaglandins 20:947–957.
  • J. Quiroga, and J. Prieto.(1993). Liver protection by prostaglandins Pharmacol. Ther 58:67–92.
  • J. Reichen, and M. Le.(1986). Verapamil favourably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver J. Clin. Invest 78:448–455.
  • R. Runkel, M. Chaplin, G. Boost, E. Segre, and E. Forchielli.(1972). Adsorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects J. Pharm. Sci 61:703–708.
  • X. Sato, H. Shinzawa, Y. Abe, T. Takahashi, S. Arai, and F. Sendo.(1993). Inhibition of corynebacterium parvum primed and lipopolysaccharide‐induced hepatic necrosis in rats by selective depletion of neutrophils using monoclonal antibodies J. Leukocyte Biol 53:144–150.
  • J. Sircar, C. Schwender, and E. Johnson.(1983). Soybean lipoxygenase inhibition by nonsteroidal anti‐inflammatory drugs Prostaglandins 25:393–396.
  • T. Tran‐Thi, K. Gyufko, D. Häussinger, and K. Decker.(1988). Net prostaglandin release by the perfused rat liver after stimulation with phorbol 12‐myristate 13‐acetate J. Hepatol 6:151–157.
  • Y. Wu, I. Brouet, S. Calmels, H. Bartsch, and H. Ohshima.(1993). Increased endogeneous N‐nitrosamine and nitrate formation by induction of nitric oxide synthase in rats with acute hepatic injury caused by propionibacterium acnes and lipopolysaccharide administration Carcinogenesis 14:7–10.
  • S. Yamada, I. Ogata, K. Hirata, S. Mochida, T. Tomiya, and K. Fujiwara.(1989). Intravascular coagulation in the development of massive hepatic necrosis induced by corynebacterium parvum and endotoxin in rats Scand. J. Gastroenterol 24:293–298.
  • D. Meijer.K. Ziegler.(1993). Biological barriers to Protein Delivery. Pharmaceutical Biotechnology339–409.
  • G. Snedecor.W. Cochran.(1967). Statistical methods

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.